Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00753116 · ClinicalTrials.gov registry record · Phase 1
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
A Phase 1 study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00753116 is a Phase 1 study that has completed, run by Medtronic Vascular. The registered enrollment target is 20 participants.
The verdict
NCT00753116, a Phase 1 study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.
Interventions
- DEVICE Renal Denervation with a catheter-based procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-09 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00753116
The ClinicalTrials.gov registry entry for NCT00753116 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Renal Denervation with a catheter-based procedure is the first listed.
NCT00753116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00753116 about?
NCT00753116 is a clinical study titled "Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension". The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.
What is the current status of trial NCT00753116?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2008-09. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00753116?
The interventions under investigation include: Renal Denervation with a catheter-based procedure (DEVICE).
Who is sponsoring clinical trial NCT00753116?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.